Patents by Inventor John S. Blanchard

John S. Blanchard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240066278
    Abstract: An instrument advancement device includes an access connector configured to be connected to a vascular access device, a primary lumen in fluid communication with the access connector, an instrument received within the primary lumen and having a retracted position and an extended position, an advancement member configured to move the instrument between the retracted position and the extended position, and a lumen seal received within the primary lumen and connected to the instrument. The lumen seal defines a space between the lumen seal and the primary lumen when the instrument is in the retracted portion. The lumen seal engages the primary lumen when the instrument is in the advanced position.
    Type: Application
    Filed: August 23, 2023
    Publication date: February 29, 2024
    Inventors: Curtis H. Blanchard, Adam J. Boud, John M. Lackey, Megan S. Scherich, Shaun Staley
  • Patent number: 8999894
    Abstract: Methods are provided for labeling and for detecting DNA-interacting proteins with an assayable label, comprising combining the DNA-interacting protein with a mfpA pentapeptide repeat family protein that has been purified and that binds to the protein, wherein the mfpA pentapeptide repeat family protein is bound to an assayable label.
    Type: Grant
    Filed: April 18, 2006
    Date of Patent: April 7, 2015
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: John S. Blanchard, Matthew W. Vetting, Subray S. Hegde
  • Publication number: 20110190253
    Abstract: The present invention generally relates to methods for treating tuberculosis in a subject comprising administering to the subject an antibiotic in conjunction with clavulanic acid or salt thereof. The antibiotic can be carbapenem (e.g., meropenem or imipenem) or cefuroxime. The present invention also relates to related pharmaceutical compositions and methods for manufacturing said pharmaceutical compositions.
    Type: Application
    Filed: May 15, 2009
    Publication date: August 4, 2011
    Inventor: John S. Blanchard
  • Patent number: 7745163
    Abstract: The present invention is directed to a method of identifying an acetyltransferase substrate in a sample that includes the steps of: (a) contacting the sample with (i) a reagent comprising a thiol-containing compound, a halo-acetyl-CoA or a halo-acetyl-pantetheine, and (ii) an acetyltransferase, under conditions suitable for acetyltransferase enzyme activity, and (b) identifying a substrate that has formed a base-stable covalent bond to the reagent, wherein the reagent is labeled with a label and/or the acetyltransferase is labeled with an affinity tag, and the substrate is the acetyltransferase substrate.
    Type: Grant
    Filed: October 1, 2004
    Date of Patent: June 29, 2010
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventor: John S. Blanchard
  • Publication number: 20090131266
    Abstract: Provided are recombinant pentapeptide repeat family proteins comprising at least one mutation of an i?1, i+1, and/or i+2 amino acid residue. Also provided are vectors comprising a nucleic acid sequence encoding the above-described pentapeptide repeat family proteins, protein libraries comprising the above pentapeptide repeat family proteins, and vector libraries comprising the above-described vectors. Additionally provided are methods of identifying a pentapeptide repeat family protein with an assayable phenotype, methods of labeling a nucleic acid-interacting macromolecule, and methods of detecting a nucleic acid-interacting macro-molecule.
    Type: Application
    Filed: April 18, 2006
    Publication date: May 21, 2009
    Inventors: John S. Blanchard, Matthew W. Vetting, Subray S. Hegde
  • Patent number: 6881553
    Abstract: The present invention provides a method of selecting a compound which inhibits the enzymatic activity of enoyl reductase which comprises: (A) contacting enoyl reductase with the compound linked to an acyl carrier protein; (B) measuring the enzymatic activity of the enoyl reductase of step (A) compared with the enzymatic activity of enoyl reductase in the absence of the compound and selecting the compound which inhibits the enzymatic activity of enoyl reductase.
    Type: Grant
    Filed: February 13, 2003
    Date of Patent: April 19, 2005
    Assignees: The Trustees of Columbia University in the City of New York, Albert Einstein College of Medicine of Yeshiva University
    Inventors: Christina Kabbash, Samuel C. Silverstein, Howard A. Shuman, John S. Blanchard
  • Publication number: 20030191146
    Abstract: The present invention provides for a method of inhibiting activity of an enoyl reductase enzyme in a cell which comprises contacting the cell with a compound having the structure: 1
    Type: Application
    Filed: February 13, 2003
    Publication date: October 9, 2003
    Applicant: The Trustees of Columbia University in the City of New York
    Inventors: Christina Kabbash, Samuel C. Silverstein, Howard A. Shuman, John S. Blanchard
  • Patent number: 6531291
    Abstract: The present invention provides a method of selecting a compound which inhibits the enzymatic activity of enoyl reductase which comprises: (A) contacting enoyl reductase with the compound linked to an acyl carrier protein; (B) measuring the enzymatic activity of the entoy reductase of step (A) compared with the enzymatic activity of enoyl reductase in the absence of the compound and selecting the compound which inhibits the enzymatic activity of enoyl reductase.
    Type: Grant
    Filed: November 10, 1999
    Date of Patent: March 11, 2003
    Assignees: The Trustees of Columbia University in the City of New York, Albert Einstein College of Medicine of Yeshiva University
    Inventors: Christina Kabbash, Samuel C. Silverstein, Howard A. Shuman, John S. Blanchard
  • Patent number: 5851810
    Abstract: The present invention provides a purified and isolated nucleic acid encoding Rhodococcus L-phenylalanine dehydrogenase. The present invention also provides a vector comprising nucleic acid encoding Rhodoccus L-phenylalanine dehydrogenase, a host cell transformed with the vector, and a method for producing recombinant L-phenylalanine dehydrogenase.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: December 22, 1998
    Assignee: Albert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva University
    Inventor: John S. Blanchard